Puhr-Westerheide, D., Cyran, C. C., Sargsyan-Bergmann, J., Todica, A., Gildehaus, F., Kunz, W. G., . . . Kazmierczak, P. M. (2019). The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma. Cancer Imaging, 19(1), . https://doi.org/10.1186/s40644-019-0263-z
Chicago-referens (17:e uppl.)Puhr-Westerheide, Daniel, et al. "The Added Diagnostic Value of Complementary Gadoxetic Acid-enhanced MRI to 18F-DOPA-PET/CT for Liver Staging in Medullary Thyroid Carcinoma." Cancer Imaging 19, no. 1 (2019). https://doi.org/10.1186/s40644-019-0263-z.
MLA-referens (9:e uppl.)Puhr-Westerheide, Daniel, et al. "The Added Diagnostic Value of Complementary Gadoxetic Acid-enhanced MRI to 18F-DOPA-PET/CT for Liver Staging in Medullary Thyroid Carcinoma." Cancer Imaging, vol. 19, no. 1, 2019, https://doi.org/10.1186/s40644-019-0263-z.
